A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study-Reference-Cited by-同舟云学术

A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

Published:2013-06 Issue:3 Volume:129 Page:486-494
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Leslie Kimberly K.,Sill Michael W.,Fischer Edgar,Darcy Kathleen M.,Mannel Robert S.,Tewari Krishnansu S.,Hanjani Parviz,Wilken Jason A.,Baron Andre T.,Godwin Andrew K.,Schilder Russell J.,Singh Meenakshi,Maihle Nita J.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference69 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2012

2. Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the Grupo Ginecologico Espanol para el Tratamiento Oncologico (GGETO);Calero;Eur J Cancer,1991

3. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study;Thigpen;Cancer Treat Rep,1979

4. A phase II study of Cis-platinum for recurrent corpus cancer;Tropé;Eur J Cancer,1980

5. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locally advanced and metastatic endometrial cancer: Current and emerging therapies;Cancer Treatment Reviews;2024-09

2. Complete radiological response when using pembrolizumab in the mono mode in the 2nd-line drug therapy of MSI-h / dMMR-positive advanced endometrial cancer. A clinical case;Surgery and Oncology;2023-12-21

3. Evolution of systemic therapy for disseminated endometrial cancer: literature review;Malignant tumours;2023-06-21

4. Radiotherapy and Chemotherapy Features in the Treatment for Locoregional Recurrence of Endometrial Cancer: A Systematic Review;Journal of Personalized Medicine;2023-05-24

5. Evaluation of the efficacy of systemic therapy for advanced uterine leiomyosarcoma: A systematic review, meta‐analysis, and meta‐regression analysis;Cancer Medicine;2023-04-20